PNC
DGX icon

Park National Corp’s Quest Diagnostics DGX Stock Holding History

Park National Corp’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-399
Closed -$84.6K – 324
2026
Q2 		$84.6K Sell
399
-80
-17% -$15.7K ﹤0.01% 331
2026
Q1 		$93.9K Buy
+479
New +$93.1K ﹤0.01% 329

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

Park National Corp's DGX Position: Q3 2026 in Review

Park National Corp sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 399 shares — an estimated $84.6K sold.

Park National Corp first reported a position in DGX in Q1 2026 and held it in 2 quarters. The position peaked at $93.9K in Q1 2026. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Park National Corp reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Park National Corp sold 399 Quest Diagnostics shares in Q3 2026, an estimated $84.6K.
  • Park National Corp first reported a position in Quest Diagnostics in Q1 2026 and held it in 2 quarters.
  • Park National Corp's Quest Diagnostics position peaked at $93.9K in Q1 2026.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Park National Corp's 13F filing for Q3 2026, filed 5 Oct 2026.